11/14/2024 3:50 PM | Inhibrx (Subject) PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
06/10/2024 4:10 PM | Inhibrx (Filer)
| Form 15-12G | |
06/03/2024 4:55 PM | HALVORSEN OLE ANDREAS (Reporting) Inhibrx (Issuer) Ott David C. (Reporting) Shabet Rose Sharon (Reporting) VIKING GLOBAL INVESTORS LP (Reporting) Viking Global Opportunities GP LLC (Reporting) Viking Global Opportunities Illiquid Investments Sub-Master LP (Reporting) Viking Global Opportunities Parent GP LLC (Reporting) Viking Global Opportunities Portfolio GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 4:56 PM | Inhibrx (Subject) VIKING GLOBAL INVESTORS LP (Filed by)
| Form SC 13G/A | |
05/31/2024 3:30 PM | Inhibrx Biosciences, Inc. (Issuer) Inhibrx (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:22 PM | Inhibrx (Issuer) Lappe Mark (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:23 PM | Inhibrx (Issuer) MANHARD KIMBERLY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:23 PM | Inhibrx (Issuer) Vuori Kristiina MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:21 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:21 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 5:22 PM | FORSYTH DOUGLAS (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Get the Latest News and Ratings for INBX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Inhibrx and its competitors with MarketBeat's FREE daily newsletter.
|
05/30/2024 5:22 PM | Inhibrx (Issuer) Kayyem Jon Faiz (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/30/2024 3:32 PM | Inhibrx (Filer)
| Form POSASR | |
05/30/2024 3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 3:33 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 3:34 PM | Inhibrx (Filer)
| Form S-8 POS | |
05/30/2024 7:39 AM | Inhibrx (Subject) Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
05/28/2024 3:55 PM | Eckelman Brendan P. (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/24/2024 5:15 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/24/2024 3:44 PM | Inhibrx Biosciences, Inc. (Issuer) Inhibrx (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
05/22/2024 8:54 AM | Eckelman Brendan P. (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 8:48 PM | Inhibrx (Filer)
| Form DEFA14A | |
05/17/2024 4:29 PM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:08 PM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:42 PM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:36 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2024 3:22 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/22/2024 3:54 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/22/2024 2:56 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/21/2024 3:36 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/20/2024 3:50 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/15/2024 3:46 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/15/2024 3:48 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 3:22 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/13/2024 10:34 AM | Eckelman Brendan P. (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/12/2024 5:04 PM | Eckelman Brendan P. (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2024 3:20 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/08/2024 2:28 PM | Deck Kelly (Reporting) Inhibrx (Subject) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/06/2024 3:41 PM | Deck Kelly (Reporting) Inhibrx (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 1:58 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
$5,000 DOGE check? (Ad) Elon Musk's DOGE agenda just took a very surprising turn...
Earlier this week, reports emerged that a portion of the savings DOGE makes in Federal cuts could be funneled back to taxpayers.
The media was quick to dub it a DOGE Dividend, with claims circulating that we could all receive a $5,000 check in the mail. Everything you need to know is right here. |
03/04/2024 5:26 PM | Deck Kelly (Reporting) Inhibrx (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/29/2024 4:26 PM | Inhibrx (Filer)
| Form PREM14A | |
02/28/2024 8:10 AM | Inhibrx (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/28/2024 8:12 AM | Inhibrx (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |